欧康维视生物-B(01477)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01477 欧康维视生物-B

未开盘 09-18 16:08:32

5.095

-0.255

-4.77%

最高5.410	最低5.095	成交量43.46万
今开5.350	昨收5.350	日振幅5.89%
总市值41.52亿	流通市值41.52亿	总股本8.15亿
成交额227.09万	换手率0.05%	流通股本8.15亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01477","market":"HK","secType":"STK","nameCN":"欧康维视生物-B","latestPrice":5.095,"timestamp":1789718912005,"preClose":5.35,"halted":0,"volume":434618,"delay":0,"changeRate":-0.04766355140186914,"floatShares":815000000,"shares":815000000,"eps":-0.2343223397244799,"marketStatus":"未开盘","change":-0.255,"latestTime":"09-18 16:08:32","open":5.35,"high":5.41,"low":5.095,"amount":2270915,"amplitude":0.058879,"askPrice":5.135,"askSize":56000,"bidPrice":5.095,"bidSize":4500,"shortable":3,"etf":0,"ttmEps":-0.18052778858223242,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1789954200000},"marketStatusCode":0,"adr":0,"listingDate":1594310400000,"exchange":"SEHK","adjPreClose":5.35,"openAndCloseTimeList":[[1789695000000,1789704000000],[1789707600000,1789718400000]],"volumeRatio":1.3288729574223768,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01477","defaultTab":"news","newsList":[{"id":"2668928752","title":"Anthropic悄悄建起生物实验室！Claude指挥机器人做实验，AI制药再进一步","url":"https://stock-news.laohu8.com/highlight/detail?id=2668928752","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668928752?lang=zh_cn&edition=full","pubTime":"2026-09-18 19:37","pubTimestamp":1789731450,"startTime":"0","endTime":"0","summary":"Anthropic在旧金山湾区悄然建立实体生物实验室，招聘生物化学人才，标志其生命科学战略从计算模拟迈向真实实验。公司通过收购、推出Claude Science及设备操控标准，推动AI直接指挥实验、加速临床前药物研发。此举发生在筹备IPO与AI生物安全争议的敏感期，数据隔离与安全风险备受关注。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"6e7a4338b1034ad785d5025385d8625c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3782086","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","QTOC","PBOT","ROBO","CHAT","VTHR","BK1191","AGIX","ARTY","01477","KOMP","AIPO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668294233","title":"一键布局AI制药，首选高含量ETF","url":"https://stock-news.laohu8.com/highlight/detail?id=2668294233","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668294233?lang=zh_cn&edition=full","pubTime":"2026-09-18 17:42","pubTimestamp":1789724520,"startTime":"0","endTime":"0","summary":"💊 一键布局AI制药，首选高含量ETF👇🏻🏥 港股通医疗ETF华宝#159137🧬 标的指数“AI制药含量”69.5%，全市场第一❗MACD金叉信号形成，这些股涨势不错！","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-09-18/doc-inisfyfa8394210.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["AIPO","VTHR","CHAT","BK1574","BK4550","AGIX","BK4585","01477","FDN","QTOC","BK4588","BK1191","ARTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668291034","title":"大行评级丨大和：中生制药管理层重申今年收入增长双位数指引，评级“买入”","url":"https://stock-news.laohu8.com/highlight/detail?id=2668291034","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668291034?lang=zh_cn&edition=full","pubTime":"2026-09-18 13:56","pubTimestamp":1789711016,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK1574","01477","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668891996","title":"AI制药概念股早盘集体走高 剂泰科技-P涨逾13%英硅智能涨逾11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2668891996","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668891996?lang=zh_cn&edition=full","pubTime":"2026-09-18 10:11","pubTimestamp":1789697460,"startTime":"0","endTime":"0","summary":"热点栏目自选股\n数据中心\n行情中心\n资金流向\n模拟交易客户端AI制药概念股早盘集体走高，截至发稿，剂泰科技-P（07666）上涨13.20%，报17.58港元；英硅智能（03696）上涨10.98%，报59.65港元；晶泰控股（02228）上涨8.34%，报7.47港元；金斯瑞生物科技（01548）上涨6.39%，报39.60港元。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-09-18/doc-inisfazi3502899.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["AIPO","ARTY","CHAT","BK1161","VTHR","01477","AGIX","BK1191","QTOC","BK1574","07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668196179","title":"“十五五”规划力挺AI制药！英硅智能大涨近13%创5月以来新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2668196179","media":"格隆汇","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668196179?lang=zh_cn&edition=full","pubTime":"2026-09-18 10:05","pubTimestamp":1789697153,"startTime":"0","endTime":"0","summary":"9月18日，港股市场英硅智能拉升大涨近13%报60.6港元，股价创5月以来新高，截至目前成交额放大至超6亿港元。英硅智能是全球AI药物研发领域的龙头标的之一。《规划》对AI制药政策面的强力支持，为其技术应用提供了最直接的政策红利与产业落地空间。","market":"us","thumbnail":"http://imgcloud.jrjimg.cn/2026/09/cms_20260918100553093.jpg","type":0,"news_type":0,"thumbnails":["http://imgcloud.jrjimg.cn/2026/09/cms_20260918100553093.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2026/09/18100558478274.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["VTHR","AIPO","BK1574","01477","CHAT","QTOC","ARTY","AGIX","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668291615","title":"港股异动 | AI制药进入战略入局阶段 剂泰科技-P(07666.HK)涨超11%领涨板块 英硅智能(03696.HK)涨超6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2668291615","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668291615?lang=zh_cn&edition=full","pubTime":"2026-09-18 09:36","pubTimestamp":1789695405,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["07666","BK1191","BK1141","03696","BK1161","01477","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668915943","title":"十部门：加快人工智能、量子计算、超级计算、计算医学等新技术赋能药物研发 探索超限制造、太空制药、生物制造等药械生产新模式","url":"https://stock-news.laohu8.com/highlight/detail?id=2668915943","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668915943?lang=zh_cn&edition=full","pubTime":"2026-09-18 09:04","pubTimestamp":1789693482,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["AIFD","NBDS","XQTM","OGIG","NEWZ","01477","PSQ","WPAI","IBBJ","DQJN","PBOT","AIQU","CPNQ","CRTC","KOMP","CHPX","QTUP","TECY","QQQ","QQA","AIBU","NJUL","QUA","TARK","161631","LCLG","ARTY","QPUX","QQQM","CQTM","FWD","MVPS","NJAN","SQQQ","CWC","LOUP","QTUM","AQGX","VUSE","WQTM","AGIX","QID","TQQQ","TQQY","GK","MFIG","QSWN","CHAT","QTOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668990558","title":"诺奖得主莱维特对话英硅智能CEO任峰，坦言AI制药发展远超他预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2668990558","media":"上观新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668990558?lang=zh_cn&edition=full","pubTime":"2026-09-18 06:00","pubTimestamp":1789682408,"startTime":"0","endTime":"0","summary":"“迈克尔，半个世纪前，您完成了全球首次蛋白质动力学模拟，那时用计算机研究生物学就像科幻小说。如今，人工智能可以预测蛋白质结构、生成全新分子、设计药物并推动它进入临床试验。人工智能+生物医药的发展速度，是否超出了您的预期？”英硅智能联合首席执行官、首席科学官任峰向诺贝尔化学奖得主、斯坦福大学教授迈克尔·莱维特提出了这个问题。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609183877705468.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609183877705468.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["QTOC","VTHR","BK1574","CHAT","AGIX","01477","AIPO","ARTY","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668692149","title":"AI制药站上风口！ETF怎么投？","url":"https://stock-news.laohu8.com/highlight/detail?id=2668692149","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668692149?lang=zh_cn&edition=full","pubTime":"2026-09-17 19:06","pubTimestamp":1789643160,"startTime":"0","endTime":"0","summary":"9月16日，AI制药领域三笔重磅合作同日落地：1、字节跳动孵化的Anew Labs完成2.9亿美元首轮外部融资正式独立。AI制药产业化加速，投资工具关注 AI制药含量近70% 港股通医疗ETF华宝#159137 AI+CRO、AI医疗 医疗ETF华宝#512170 AI+Biotech 港股通创新药ETF华宝#520880 AI+Biotech 药ETF华宝#562050 投龙头 · 选华宝 市场有风险 投资须谨慎！","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-09-17/doc-iniscvfx3581124.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4550","CHAT","BK4588","FDN","ARTY","AIPO","VTHR","01477","QTOC","AGIX","BK1191","BK4585","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668968254","title":"汇宇制药(688553.SH)股东黄干益拟被动减持不超2.46%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2668968254","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668968254?lang=zh_cn&edition=full","pubTime":"2026-09-17 17:19","pubTimestamp":1789636777,"startTime":"0","endTime":"0","summary":"智通财经APP讯，汇宇制药(688553.SH)发布公告，公司于近日收到股东黄干益出具的《关于被动减持计划告知函》，股东黄干益计划在履行减持股份预先披露义务的十五个交易日后的90天内(即2026年10月19日——2027年1月16日)合计减持不超过1539.23万股，占公司总股本比例不超过2.46%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1497411.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688553","BK1574","BK1191","01477","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668518799","title":"诺和诺德、礼来、字节系落子AI制药，A股创新药、CRO板块嗨了","url":"https://stock-news.laohu8.com/highlight/detail?id=2668518799","media":"华尔街见闻","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668518799?lang=zh_cn&edition=full","pubTime":"2026-09-17 14:26","pubTimestamp":1789626360,"startTime":"0","endTime":"0","summary":"诺和诺德与Anthropic达成AI合作，金斯瑞携手礼来TuneLab平台提供湿实验验证，字节拆分的Anew Labs亦获2.9亿美元融资。多重重磅合作与融资密集落地，显现AI制药协作热潮，带动A股创新药、CRO板块大涨。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"6e7a4338b1034ad785d5025385d8625c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3781972","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["399300","02846","ARTY","03130","06978","159992","82846","02827","LNGR","159982","83188","03188","AIPO","BK1161","07233","VTHR","BGIA","MEDX","CHAT","01477","BK1147","QTOC","83130","AGIX","IBBQ","BK1574","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668796959","title":"BD高增叠加AI制药大消息！CRO概念大涨 机构看好行业“量价齐升”(附股)","url":"https://stock-news.laohu8.com/highlight/detail?id=2668796959","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668796959?lang=zh_cn&edition=full","pubTime":"2026-09-17 14:14","pubTimestamp":1789625668,"startTime":"0","endTime":"0","summary":"9月17日早盘，医药板块全线走强，CRO概念逆势领涨，金石亚药20cm封板，百花医药亦强势涨停，近岸蛋白、万邦医药涨超10%，义翘神州、康希诺、宣泰医药、奥浦迈等多股跟涨。　　消息面上，诺和诺德与Anthropic达成合作，将使用ClaudeScience平台助力新药研发；同时，我国创新药出海步伐提速，对外授权交易总额已突破1200亿美元。作为产业链上的“卖水人”，CRO赛道景气度持续上行，有机构指出，CXO行业正从短期修复转向成长定价。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260917/32372898.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["CHAT","ARTY","AGIX","QTOC","01477","AIPO","VTHR","BK1191","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668930747","title":"港股异动 | 英硅智能(03696)盘中涨超6% 公司首款AI药物展现抗衰潜力 机构看好AI制药商业化爆发","url":"https://stock-news.laohu8.com/highlight/detail?id=2668930747","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668930747?lang=zh_cn&edition=full","pubTime":"2026-09-17 10:30","pubTimestamp":1789612210,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，英硅智能盘中最高涨逾6%，截至发稿，涨4.87%，报52.75港元，成交额2.85亿港元。消息面上，此前，英硅智能开发的一款用于治疗肺部疾病的实验性药物Rentosertib，在逆转生物衰老标志物方面展现出积极前景。目前该药物已迈入临床III期。花旗认为，英硅智能仍为该行人工智能药物发现子板块首选。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1497233.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","BK4588","KCAI","VXUS","ARTY","BK1191","VTHR","AGIX","01477","CHAT","AIPO","BK1141","QTOC","03696","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668307289","title":"港股异动 | 英硅智能(03696.HK)盘中涨超6% 公司首款AI药物展现抗衰潜力 机构看好AI制药商业化爆发","url":"https://stock-news.laohu8.com/highlight/detail?id=2668307289","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668307289?lang=zh_cn&edition=full","pubTime":"2026-09-17 10:30","pubTimestamp":1789612210,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1141","BK1574","01477","BK1191","03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668793089","title":"诺和诺德跨界合作Anthropic，AI制药股走强，百普赛斯涨近15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2668793089","media":"格隆汇","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668793089?lang=zh_cn&edition=full","pubTime":"2026-09-17 09:44","pubTimestamp":1789609455,"startTime":"0","endTime":"0","summary":"9月17日，A股市场AI制药股集体上涨，其中，百普赛斯涨近15%，泓博医药涨7%，协创数据涨超5%，华大智造涨超3%，华兰股份、贝瑞基因、百奥赛图涨近3%。消息面上，诺和诺德与Anthropic宣布达成合作，双方将利用Anthropic的人工智能(AI)模型及Claude Science支持药物发现与研发。\n\n港股频道更多独家策划、专家专栏，免费查阅>>\n\n            责任编辑：栎树","market":"sh","thumbnail":"http://imgcloud.jrjimg.cn/2026/09/cms_20260917094415461.jpg","type":0,"news_type":0,"thumbnails":["http://imgcloud.jrjimg.cn/2026/09/cms_20260917094415461.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2026/09/17094458468069.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["AGIX","CHAT","AIPO","BK0216","BGIA","BK1191","ARTY","BK1574","QTOC","VTHR","01477","301080"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667005796","title":"字节拆出一家AI制药公司，首轮融资2.9亿美元，估值15亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2667005796","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667005796?lang=zh_cn&edition=full","pubTime":"2026-09-16 19:02","pubTimestamp":1789556520,"startTime":"0","endTime":"0","summary":"头部AI大厂将生命科学视为核心战略业务布局。9月16日，据市场消息，自字节跳动分拆出来的AI制药业务Anew Labs独立完成2.9亿美元首轮融资，投后估值约15亿美元。Anew Labs前身为字节跳动内部AI for Science药物发现团队，2021年由刘凯牵头组建，核心成员约50人。独立后的Anew Labs定位端到端AI新药发现公司，核心管线为全球首个可同时抑制IL-17家族三类二聚体的小分子抑制剂。字节的拆分动作，是当前AI大厂布局生物制药的一个缩影。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2026-09-16/doc-inirzmzc0553744.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-09-16/doc-inirzmzc0553744.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["01477","BK1574","CHAT","VTHR","AGIX","AIPO","BK1191","ARTY","QTOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667617679","title":"创新药概念局部走强 恒瑞医药（01276）涨2.74% 机构料企业扭亏节点到来","url":"https://stock-news.laohu8.com/highlight/detail?id=2667617679","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667617679?lang=zh_cn&edition=full","pubTime":"2026-09-16 10:20","pubTimestamp":1789525259,"startTime":"0","endTime":"0","summary":"消息面上，国金证券表示，创新药企业扭亏节点到来，全年临床数据催化密集，叠加已BD出海管线海外临床进展顺利，看好创新药板块投资机会。诚通证券表示，2025年为创新药海外授权BD大年，2026H1我国创新药海外授权BD交易继续大幅增长，总交易金额已接近1000亿美元，国产创新药已从偶发性出海转变为系统性趋势。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250110/NTQxOTRlZTU5ZGZkZjc4MmEzMTdjMTVhMTM1NjYxOTg3NzU=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/NTQxOTRlZTU5ZGZkZjc4MmEzMTdjMTVhMTM1NjYxOTg3NzU=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1991724","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0516422952.EUR","LU0348825331.USD","KURE","LU0140636845.USD","LU1328615791.USD","IE00B0JY6N72.USD","LU2580892789.USD","600276","BK0239","LU0128526141.USD","LNGR","LU0417516902.SGD","LU0516423174.USD","LU1146622755.USD","LU0359201612.USD","IBBQ","06978","01177","LU1255011170.USD","02637","LU0588546209.SGD","BK0188","LU2097828557.USD","MEDX","LU2488822045.USD","LU2097828805.USD","LU0348827113.USD","IE00BZ08YS42.EUR","01477","BK1574","LU1820825898.SGD","LU2039709279.SGD","BK1515","02269","LU1655091616.SGD","BK0183","LU1580142542.USD","01276","LU0043850808.USD","LU1997244956.HKD","159992","LU0307460666.USD","LU1023057109.AUD","LU2148510915.USD","09688","LU0327786744.USD","LU0561508036.HKD","LU0405327148.USD","BK0060","LU0456846285.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667346679","title":"港股异动 | 欧康维视生物-B(01477.HK)涨超3% 近日OT-301新药上市注册申请获国家药监局受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2667346679","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667346679?lang=zh_cn&edition=full","pubTime":"2026-09-16 10:20","pubTimestamp":1789525205,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1191","BK1574","01477"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667564486","title":"凌愈制药高端复杂注射剂项目奠基：攻坚“制剂皇冠明珠”，“中国制造”剑指全球市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2667564486","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667564486?lang=zh_cn&edition=full","pubTime":"2026-09-15 19:34","pubTimestamp":1789472040,"startTime":"0","endTime":"0","summary":"9月15日，浙江凌愈制药有限公司高端复杂注射剂项目奠基仪式在浙江台州举行。复杂注射剂被誉为“制剂工业皇冠上最难摘的明珠”，涵盖微球、脂质体、长效缓释制剂等前沿剂型，是医药产业迈向全球价值链高端的关键突破口。凌愈制药由海正药业与圣兆药物于2025年12月合资组建。本次项目奠基，不仅是一座工厂的破土动工，更是国产高端复杂注射剂跻身全球高端制剂市场的郑重宣言。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-09-15/doc-inirxhzq8487339.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","BK1191","01477"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667467806","title":"全球首个！上海交大教授创办，AI制药拿下C1轮融资","url":"https://stock-news.laohu8.com/highlight/detail?id=2667467806","media":"智药局","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667467806?lang=zh_cn&edition=full","pubTime":"2026-09-15 18:00","pubTimestamp":1789466400,"startTime":"0","endTime":"0","summary":"今日，宇道生物宣布完成数千万美元的C1轮融资。一家专攻难成药靶点的公司宇道生物是国内最早依托“AI+物理”双轮驱动技术，系统性攻克难成药靶标药物研发的行业龙头企业之一，由AI+变构领域全球顶级科学家、上海交通大学特聘教授张健创立。技术方面，公司搭建了全球规模领先的蛋白构象调控数据库AlloMatrix，并自研拥有自主知识产权的AI+物理计算平台AlloStar。本轮融资主要用于加速AI+物理计算平台迭代和核心管线。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-09-15/doc-inirxats8585013.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["VTHR","ARTY","QTOC","BK1191","AGIX","AIPO","01477","CHAT","BK1574"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ocumension.com","stockEarnings":[{"period":"1week","weight":-0.0441},{"period":"1month","weight":-0.0221},{"period":"3month","weight":0.0419},{"period":"6month","weight":-0.2659},{"period":"1year","weight":-0.4269},{"period":"ytd","weight":-0.3115}],"compareEarnings":[{"period":"1week","weight":-0.0022},{"period":"1month","weight":-0.0292},{"period":"3month","weight":0.0345},{"period":"6month","weight":-0.0208},{"period":"1year","weight":-0.0676},{"period":"ytd","weight":-0.0343}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"欧康维视生物是一家主要从事眼科药物的研发和商业化的公司。该公司产品主要包括OT-401“优施莹”氟轻松玻璃体内植入剂、OT-702“博优景”阿柏西普眼内注射溶液、OT-402“维速达尔”注射用维替泊芬、OT-204“欧沁”玻璃酸钠滴眼液及OT-305“贝特舒”盐酸倍他洛尔滴眼液等。该公司产品主要用于治疗葡萄膜炎、眼底疾病、屈光矫正、干眼症（DED）、青光眼及角结膜炎等各种眼前及眼后段疾病。该公司主要在中国国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.166667,"avgChangeRate":-0.097698},{"month":2,"riseRate":0.5,"avgChangeRate":-0.037557},{"month":3,"riseRate":0.5,"avgChangeRate":0.044668},{"month":4,"riseRate":0.5,"avgChangeRate":0.015642},{"month":5,"riseRate":0.5,"avgChangeRate":0.087204},{"month":6,"riseRate":0.666667,"avgChangeRate":0.062947},{"month":7,"riseRate":0.5,"avgChangeRate":-0.003589},{"month":8,"riseRate":0.428571,"avgChangeRate":-0.052517},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.072946},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.121217},{"month":11,"riseRate":0.333333,"avgChangeRate":0.004503},{"month":12,"riseRate":0.5,"avgChangeRate":0.058088}],"exchange":"SEHK","name":"欧康维视生物-B","nameEN":"OCUMENSION-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.0","shortVersion":"4.50.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"欧康维视生物-B(01477)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供欧康维视生物-B(01477)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"欧康维视生物-B,01477,欧康维视生物-B股票,欧康维视生物-B股票老虎,欧康维视生物-B股票老虎国际,欧康维视生物-B行情,欧康维视生物-B股票行情,欧康维视生物-B股价,欧康维视生物-B股市,欧康维视生物-B股票价格,欧康维视生物-B股票交易,欧康维视生物-B股票购买,欧康维视生物-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"欧康维视生物-B(01477)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供欧康维视生物-B(01477)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}